Research participants
ChiCTR2100044063
This study is a multi-center clinical study. We enrolled 171 patients who were admitted to 18 medical institutions in China with Zhejiang Hospital as the lead unit, from April 23, 2021 to October 31, 2022. The study protocol was reviewed and approved by the ethics committees of Zhejiang Hospital and its sub-centers, and was registered on the website of China Clinical Trial Registration Center (ChiCTR2100044063, March 9, 2021).